Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME)-Reference-Cited by-同舟云学术

Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME)

Published:2016-05-18 Issue:6 Volume:63 Page:812-817
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Evans Scott R.,Pennello Gene,Pantoja-Galicia Norberto,Jiang Hongyu,Hujer Andrea M.,Hujer Kristine M.,Manca Claudia,Hill Carol,Jacobs Michael R.,Chen Liang,Patel Robin,Kreiswirth Barry N.,Bonomo Robert A.

Funder

National Institutes of Health (NIH)

National Institute of Allergy and Infectious Diseases

NIH

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/63/6/812/7080390/ciw329.pdf

Reference16 articles.

1. A Quality-of-Life-Oriented Endpoint for Comparing Therapies

2. Three measures for simultaneously evaluating benefits and risks using categorical data from clinical trials

3. Regression analysis based on pairwise ordering of patients' clinical histories

4. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

5. Egan JP . Signal detection theory and ROC analysis. New York: Academic Press, 1975.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DxGoals: A Software Tool for Determining and Analyzing Clinically Meaningful Classification Accuracy Goals for Diagnostic Tests;The Journal of Applied Laboratory Medicine;2024-09

2. Clinical scoring model for predicting cefotaxime-resistance in Klebsiella pneumoniae bacteremia: development and validation based on portal of entry;Journal of Chemotherapy;2024-05-23

3. Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible;Clinical Infectious Diseases;2024-02-08

4. Comparison of three rapid diagnostic tests for bloodstream infections using Benefit-risk Evaluation Framework (BED-FRAME);Journal of Clinical Microbiology;2024-01-17

5. The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations;Clinical Infectious Diseases;2023-10-15